Medicinal Products Licensing

Dáil Éireann Debate, Wednesday - 12 April 2017

Wednesday, 12 April 2017

Questions (259)

James Browne

Question:

259. Deputy James Browne asked the Minister for Health the status of the drug translarna for the treatment of Duchenne muscular dystrophy; the reason it is not approved here; the history of its applicatory process through the NCPE process; and if he will make a statement on the matter. [18382/17]

Written answers

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.